Research Article
P Wave Duration/P Wave Voltage Ratio Plays a Promising Role in the Prediction of Atrial Fibrillation: A New Player in the Game
Table 5
Medications taken by all patients.
| | | New-onset atrial fibrillation (n = 150) | Nonatrial fibrillation (n = 490) | value |
| | ASA (%) | 97 (64.7) | 346 (70.6) | 0.167 | | ACE inhibitors/ARB (%) | 111 (74.0) | 339 (69.2) | 0.259 | | Beta blockers (%) | 74 (49.3) | 228 (46.5) | 0.547 | | CA channel blockers (%) | 48 (32.0) | 191 (39.0) | 0.122 | | OAD (%) | 49 (32.7) | 193 (39.4) | 0.137 | | Insulin (%) | 17 (11.3) | 61 (12.4) | 0.715 | | Statins (%) | 37 (24.7) | 147 (30.0) | 0.207 | | MRA (%) | 13 (8.7) | 36 (7.3) | 0.595 | | Diuretics (%) | 17 (11.3) | 42 (8.6) | 0.306 |
|
|
Data are presented as n (%). ACE: angiotensin-converting enzyme; ARB: angiotensin receptor blocker; ASA: acetylsalicylic acid; CA: calcium; OAD: oral antidiabetic; MRA: mineralocorticoid receptor antagonists.
|
